DK1069893T3 - Anvendelse af dexmedetomidin til sedering på en intensivafdeling - Google Patents

Anvendelse af dexmedetomidin til sedering på en intensivafdeling

Info

Publication number
DK1069893T3
DK1069893T3 DK99913332T DK99913332T DK1069893T3 DK 1069893 T3 DK1069893 T3 DK 1069893T3 DK 99913332 T DK99913332 T DK 99913332T DK 99913332 T DK99913332 T DK 99913332T DK 1069893 T3 DK1069893 T3 DK 1069893T3
Authority
DK
Denmark
Prior art keywords
dexmedetomidine
sedation
intensive care
care unit
intensive
Prior art date
Application number
DK99913332T
Other languages
Danish (da)
English (en)
Inventor
Riku Aantaa
Romeo Bachand
Esa Heinonen
Original Assignee
Orion Corp
Hospira Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26763325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1069893(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corp, Hospira Inc filed Critical Orion Corp
Application granted granted Critical
Publication of DK1069893T3 publication Critical patent/DK1069893T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99913332T 1998-04-01 1999-03-31 Anvendelse af dexmedetomidin til sedering på en intensivafdeling DK1069893T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8028798P 1998-04-01 1998-04-01
US11094498P 1998-12-04 1998-12-04
PCT/FI1999/000266 WO1999049854A2 (en) 1998-04-01 1999-03-31 Use of dexmedetomidine for icu sedation

Publications (1)

Publication Number Publication Date
DK1069893T3 true DK1069893T3 (da) 2007-03-19

Family

ID=26763325

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99913332T DK1069893T3 (da) 1998-04-01 1999-03-31 Anvendelse af dexmedetomidin til sedering på en intensivafdeling

Country Status (27)

Country Link
EP (1) EP1069893B1 (ja)
JP (1) JP4606581B2 (ja)
KR (1) KR20010034728A (ja)
CN (1) CN1168441C (ja)
AR (1) AR015744A1 (ja)
AT (1) ATE347359T1 (ja)
AU (1) AU754484B2 (ja)
BG (1) BG64540B1 (ja)
BR (1) BR9909872A (ja)
CA (1) CA2326339C (ja)
CZ (1) CZ301013B6 (ja)
DE (1) DE69934305T2 (ja)
DK (1) DK1069893T3 (ja)
EA (1) EA005524B1 (ja)
ES (1) ES2278441T3 (ja)
GB (1) GB2352972B (ja)
HU (1) HU229162B1 (ja)
IL (1) IL138416A (ja)
NO (1) NO329194B1 (ja)
NZ (1) NZ507203A (ja)
PL (1) PL192517B1 (ja)
PT (1) PT1069893E (ja)
SI (1) SI1069893T1 (ja)
SK (1) SK286160B6 (ja)
TR (1) TR200002837T2 (ja)
TW (1) TW552136B (ja)
WO (1) WO1999049854A2 (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030347A1 (en) 1999-10-29 2001-05-03 Orion Corporation Treatment or prevention of hypotension and shock
RU2297216C2 (ru) * 2002-04-08 2007-04-20 Эм-Джи-Ай Джи-Пи,Инк. Фармацевтические композиции, содержащие растворимые в воде пролекарства пропофола, и способы их применения
US7141597B2 (en) * 2003-09-12 2006-11-28 Allergan, Inc. Nonsedating α-2 agonists
US20060058700A1 (en) * 2004-08-26 2006-03-16 Marro Dominic P Patient sedation monitor
JP2010504359A (ja) 2006-09-20 2010-02-12 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 局部麻酔および/または疼痛緩和のための、揮発性麻酔剤を送達するための方法
DK2244737T3 (da) 2008-01-22 2019-07-08 Univ Texas Flygtige anæstetiske sammensætninger omfattende ekstraktionsopløsningsmidler til regional anæstesi og/eller smertelindring
KR101859486B1 (ko) * 2009-05-15 2018-06-28 레크로파마, 인코포레이티드 설하용 덱스메데토미딘 조성물과 그의 사용 방법
DE102009050016A1 (de) 2009-05-27 2011-05-05 Modine Manufacturing Co., Racine Wärmeübertragereinheit
US20130096170A1 (en) * 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
AU2012352528B9 (en) 2011-12-11 2017-11-02 Baudax Bio, Inc. Intranasal dexmedetomidine compositions and methods of use thereof
US8242158B1 (en) * 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
JP5921928B2 (ja) * 2012-03-28 2016-05-24 テルモ株式会社 既希釈デクスメデトミジン製剤
NZ706990A (en) * 2012-10-15 2017-12-22 Orion Corp A veterinary method of alleviating noise aversion
CN105473669A (zh) 2013-07-24 2016-04-06 I-技术有限公司 作为抑制剂的对映异构体左旋美托咪啶在海洋生物污损表面附着的应用
US10772871B2 (en) 2013-10-07 2020-09-15 Teikoku Pharma Usa, Inc. Dexmedetomidine transdermal delivery devices and methods for using the same
TWI709417B (zh) * 2013-10-07 2020-11-11 美商帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
EP3054930B1 (en) 2013-10-07 2020-12-02 Teikoku Pharma USA, Inc. Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine
CN113975273B (zh) * 2020-07-27 2023-07-11 宜昌人福药业有限责任公司 一种抗焦虑用纳米混悬鼻腔喷雾剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5217718A (en) * 1989-08-18 1993-06-08 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
GB2281206A (en) * 1993-08-25 1995-03-01 Orion Yhtymae Oy Use of dexmedetomidine

Also Published As

Publication number Publication date
CN1295473A (zh) 2001-05-16
CA2326339C (en) 2008-12-23
DE69934305D1 (de) 2007-01-18
ES2278441T3 (es) 2007-08-01
CZ20003484A3 (cs) 2002-01-16
WO1999049854A3 (en) 1999-11-18
CZ301013B6 (cs) 2009-10-14
PT1069893E (pt) 2007-01-31
TW552136B (en) 2003-09-11
BG64540B1 (bg) 2005-07-29
PL343553A1 (en) 2001-08-27
CN1168441C (zh) 2004-09-29
AR015744A1 (es) 2001-05-16
WO1999049854A2 (en) 1999-10-07
SK286160B6 (sk) 2008-04-07
GB0024932D0 (en) 2000-11-29
IL138416A (en) 2005-07-25
NO20004931L (no) 2000-09-29
AU3149499A (en) 1999-10-18
TR200002837T2 (tr) 2001-01-22
NO20004931D0 (no) 2000-09-29
BG104797A (en) 2001-07-31
ATE347359T1 (de) 2006-12-15
SI1069893T1 (sl) 2007-04-30
NZ507203A (en) 2003-03-28
PL192517B1 (pl) 2006-10-31
IL138416A0 (en) 2001-10-31
CA2326339A1 (en) 1999-10-07
SK14362000A3 (sk) 2002-03-05
EP1069893A2 (en) 2001-01-24
JP2002509880A (ja) 2002-04-02
GB2352972B (en) 2003-05-21
DE69934305T2 (de) 2007-07-12
EA200001010A1 (ru) 2001-02-26
KR20010034728A (ko) 2001-04-25
NO329194B1 (no) 2010-09-13
BR9909872A (pt) 2007-11-20
JP4606581B2 (ja) 2011-01-05
HU229162B1 (hu) 2013-09-30
HUP0101498A1 (hu) 2002-03-28
EA005524B1 (ru) 2005-04-28
AU754484B2 (en) 2002-11-14
HUP0101498A3 (en) 2002-06-28
EP1069893B1 (en) 2006-12-06
GB2352972A (en) 2001-02-14

Similar Documents

Publication Publication Date Title
DK1069893T3 (da) Anvendelse af dexmedetomidin til sedering på en intensivafdeling
NO20005215L (no) Dihydropyrimidiner
FR2842417B1 (fr) Composition cosmetique
ID27768A (id) Komposisi-komposisi perawatan rambut
ID26776A (id) Komposisi-komposisi perawatan rambut
DK0965343T3 (da) Ziprasidonformuleringer
DE60016672D1 (de) Körpersreinigungsfolie
DE69900634D1 (de) Shampoozusammensetzungen
DE60321791D1 (de) Dynamisches routen in netzwerken
DK1067905T3 (da) Bruseformuleringer
ATE214590T1 (de) Körperpflegezusammensetzungen
DE69805443D1 (de) Sachet-formulierungen
ITMI991754A0 (it) Composizioni cosmetiche
ID30590A (id) Celana sekali pakai jenis-celana pendek
NO20043418L (no) Stabiliserte adenovirusformuleringer
FR2788058B1 (fr) Compositions cosmetiques amincissantes
AR028087A1 (es) Composiciones cosmeticas
DE50101916D1 (de) Flüssige formulierungen
DE69902473D1 (de) Kosmetikzusammensetzung
DK1498124T3 (da) Anvendelse af inhibitorer i renin-angiotensinsystemet
DE50110553D1 (de) Verwendung herbizider Mittel
FR2781231B1 (fr) Compositions cosmetiques amincissantes
ID30226A (id) Komposisi penat rambut
DE60111988D1 (de) Kosmetische Zusammensetzung
ID27215A (id) Komposisi perawatan rambut